Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Artemis will take Americans to the moon for the 1st time since 1972. Why has it been so hard to go back? - 2An Excursion Through Renowned Western Network programs
- 315 skywatching events you won't want to miss in 2026
- 4Manual for Vegetarian Protein Powder
- 5'All Her Fault' ending explained: The shocking conclusion to the psychological thriller inspired by true events
- Reactions as Artemis II astronauts lift off on historic lunar mission
- ICAS calls for clearer safeguards in FRC’s TCA policy
- Understanding Various Sorts of Financial balances: An Extensive Outline
- 'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
- Pick Your #1 Japanese Food
- Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.
- Arctic sea ice hits lowest winter level as heat records are shattered worldwide
- Fake new headlights rule steer Australian drivers astray
- There are thousands of aligned holes in Peru. Archaeologists now think they know who made them
